Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Oncology·MeSH: Adenocarcinoma
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Cadonilimab | Merus N.V. (MRUS) |
Phase 4(1)
| Drug | Company |
|---|---|
| SOX chemotherapy | Merus N.V. (MRUS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma?
BioSniper tracks 2 drugs in development for Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma across 1 company.
How many clinical trials target Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma?
There are 1 clinical trial targeting Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma tracked by BioSniper.
Deep-dive into Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis